MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Microfabricated Particles Useful as MRI Contrast Agents

National Institutes of Health (NIH)
These microstructures can be engineered to appear as different effective colors when resolved using MRI as opposed to strictly grey-scale contrast of existing MRI agents.

Full description

MRI contrast agents are versatile yet lack the sensitivity and multiplexing capabilities of optical agents.  Available for licensing is an invention pertaining to microfabricated structures that can be used as MRI contrast agents with enhanced functionality or as micro-RFID (radio-frequency identification) tags.  The microstructures can be engineered to appear as different effective colors when resolved using MRI as opposed to strictly grey-scale contrast of existing MRI agents.  In this way they can be thought as radio-frequency analogs to quantum dots.  A set of agents could be produced that would enable in vivo labeling and tracking of multiple different types of cells simultaneously.  The agents can also act as radio-frequency probes of various physiological conditions.  The invention can include a plurality of microstructures dispersed a liquid.  The structures can have magnetic portions that vary in size, thickness and shape that are arranged to provide a substantially uniform Larmor precession frequency or a characteristic substantially uniform shift in Larmor precession frequency experienced by nuclear magnetic moments of a material when it is located in the substantially uniform field region created by the magnetic portions.  In some embodiments, each of the nuclear magnetic resonance microstructures has a maximum dimension less than about 1 mm.  The magnetic portions of the microstructure can be arranged proximate to each other, in contact with each other or be partially, substantially or totally coincident.

 

Applications:

Magnetic Resonance Imaging

Cancer

Cardiovascular diseases imaging

Drug development

Drug candidate distribution tracking

Diagnostics

Microfluidics

 

Publications:

  1. G Zabow et al. Micro-engineered local field control for high-sensitivity multispectral MRI. Nature 2008 Jun 19;453(7198):1058-1063.  [PubMed abs]
  2. KA Hinds et al. Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood 2003 Aug 1;102(3):867-872.  [PubMed abs]

Patent information

U.S. Provisional Application No. 61/071,263 filed 18 Apr 2008 (HHS Reference No. E-081-2008/0-US-01)

 

Inventors:

Gary Zabow, Stephen Dodd (NINDS), Alan Koretsky (NINDS), John Moreland (NIST)

 

 

Type of business relationship sought

Licensees Sought:

Available for licensing.

 

Collaborative Research Opportunity:

NINDS Laboratory of Functional and Molecular Imaging is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize the use of microfabricated devices as MRI contrast agents.  Please contact Dr. Melissa Maderia at 301-451-3943 or maderiam@mail.nih.gov for more information.

 

Licensing contact

Michael Shmilovich
Senior Licensing and Patenting Manager
Office of Technology Transfer

Contact directly

Company details

National Institutes of Health (NIH)

The NIH supports and conducts basic, clinical, and translational medical research, and investigates the causes, treatments, and cures for both common and rare diseases.

View profile

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Related categories

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us